The federal judge in Trenton overseeing multidistrict litigation over allegedly improper marketing of blood pressure drug Plavix has granted motions by defendants Bristol-Myers Squibb and Sanofi-Aventis U.S. to dismiss the majority of claims in a False Claims Act case related to the drug.
U.S. District Judge Freda Wolfson of the District of New Jersey dismissed claims under the False Claims Act related to Medicare Part D and the Medicare plans of 33 states, as well as claims based on state formularies. Also dismissed were state law claims based on the laws of 43 states. The judge declined to dismiss FCA claims for 17 states, and state law claims for seven states.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
